VIVUS Initiates Safety Study for Erectile Dysfunction Drug
Pharmaceutical company VIVUS has initiated an open label safety study of the investigational drug avanafil in males with erectile dysfunction.
Articles by bjohnson56
Transcend Medical Raises $20 Million for Glaucoma Device
VentureWire reports that Transcend Medical, a developer of devices to treat glaucoma, has raised $20 million in equity.
[Company Profile] Vasonova
Every year, millions of U.S. patients are outfitted with a PICC line, a catheter threaded to the superior vena cava from the arm for the administration of treatments such as antibiotics or chemotherapy.
FDA Approves Ankle-Replacement System
The U.S. Food and Drug Administration has approved the Scandinavian Total Ankle Replacement (S.T.A.R.) System for patients with arthritic or deformed ankles.
Burrill Report: Financing Activity May Lift Cloud Hanging Over Biotech Industry
While biotech leaders from all over the world gathered at the 2009 BIO International Convention in Atlanta, financing activity in the sector raised hope that the cloud hanging over the industry may be lifting a little.
Explore Investment and Networking Opportunities at IN3 East
Hundreds of companies such as Bain Capital Ventures, Becton Dickinson, Covidien, DePuy Mitek Worldwide, Kimberly-Clark, Medtronic, Novartis BioVenture Fund, Quaker BioVentures, Siemens Venture Capital, Stryker […]
Sonitus Medical Attracts CIA Dollars
Sonitus Medical Inc., developer of a non-surgical hearing aid that is designed to transmit sound via the teeth, announced that it has received an investment from In-Q-Tel, a strategic investment firm that was started by the CIA.
Biogen Idec, Electro-Optical Among “5 Stocks Approaching Greatness”
Investment website The Motley Fool has published a list of five stocks approaching greatness–and four of them are within the life sciences industry.
Clarient Stock Deal Frees Up Cash for Safeguard Scientifics
Safeguard Scientifics Inc. has received $19.5 million in cash, and freed up another $12.3 million in cash due to one of its portfolio companies completing the second part of a private placement of convertible preferred stock.
Compounds in Plant DNA May Help Humans
That little houseplant sitting on your windowsill could one day save your life.